A new use for medical purposes

 

The invention relates to medicine, namely to a gastroenterologist, and for the treatment of symptoms of functional dyspepsia associated with the impaired ability of the gastroduodenal mucosa to neutralize the acid. To do this, use derivatives biphenylmethanol General formula I are antagonists of angiotensin II receptors of the 1st type. The invention allows to reduce the symptoms of functional dyspepsia through effects on the renin-angiotensin system. 3 S. and 7 C.p. f-crystals, 1 table.

Description text in facsimile form (see graphic part). T3

Claims

1. The use of compounds of General formula Iin which a represents an







or its physiologically acceptable Sol is the symptoms of functional dyspepsia, associated with the impaired ability of the gastroduodenal mucosa to neutralize the acid.

2. Application under item 1 of the compounds of formula I in which a represents a I:1.

3. Application under item 1 of the compounds of formula I in which a represents a I:5.

4. Pharmaceutical formulation for use in the prevention and/or treatment of symptoms of functional dyspepsia associated with the impaired ability of the gastroduodenal mucosa to neutralize the acid, in which the active ingredient is a compound under item 1.

5. Pharmaceutical drug under item 4 in the form of a standard dose.

6. Pharmaceutical drug on the PP.4 and 5, containing the active ingredient in combination with pharmaceutically acceptable carrier.

7. Pharmaceutical drug on the PP.4-6, containing as active ingredient a compound of the formula I in which a represents a I:1.

8. Pharmaceutical drug on the PP.4-6, containing as active ingredient a compound of the formula I in which a represents a I:5.

9. Method for the prevention and treatment of symptoms of functional dyspepsia associated with the impaired ability of the gastroduodenal mucosa to neutralize the acid in mammals, including humans, and treatment.

10. The method according to p. 9, characterized in that the effect of the compound of the formula I in which a is a I:1 I:5.

 

Same patents:

The invention relates to medicine

The invention relates to medicine

The invention relates to medicine

The invention relates to medicine, more specifically to pharmaceutical compositions for the treatment of diseases of the pancreas and digestive disorders associated with liver disease

The invention relates to a form of omeprazole, which is effective as an inhibitor of the secretion of gastric acid and is useful as an antiulcer agent

The invention relates to medicine and for the treatment and prevention of cholelithiasis

The invention relates to pharmaceutical compositions containing the inhibitor nm g COA reductase (E.)-7-[4-(4-forfinal)-6-isopropyl-2-[methyl(methylsulphonyl)amino] pyrimidine-5-yl]-(3R, 5S)-3,5-dihydroxide-6-envoy acid or its pharmaceutically acceptable salt as an active ingredient

The invention relates to new derivatives of arylpiperazines General formula I, where X Is O or S1- C1-C4alkoxy, CF3, R2- C1-C6alkyl, saturated WITH3-C6cycloalkyl; heteroseksualci of 3-6 ring atoms, heteroatom of which is O, S or N, optionally N-substituted WITH1-C6by alkyl; phenyl, optionally substituted by F, Cl, Br, NH2CH3CF3or OCH3; 5-6-membered heteroaryl, the heteroatom of which is O, S or N, possibly substituted, or condensed heteroaromatic system containing 9 atoms

The invention relates to 4-geterotsiklicheskikh-6-methoxy-5-(2-methoxyphenoxy)-2-pyridinedimethanol derivative of the formula I, in which R1denotes a heterocyclic fragment selected from pyridyl and thiazolyl, where the heterocyclic fragment optionally may be substituted (NISS

The invention relates to organic chemistry, namely to new derivatives of benzoperylene

The invention relates to the field of medicine

The invention relates to novel 2,4-dioxo-5-arylidene-1,3-pyrimidines of General formula I, where R is independently selected from the group: H, HE, lowest alkoxyl, halogen, nitro, di(lower)alkylamino, n = 1-3, or two adjacent R along the benzene ring to which they are attached, when n = 2, 4 form a benzo, and dibenzo when n = 2 form a 3,4-dioxolane ring

The invention relates to the field of medicine and medical equipment, and concerns the application sulfamido General formula (I) as therapeutically active substances for disorders of the Central nervous system and for the preparation of the drugs
The invention relates to medicine, namely to dermatology, and can be used in the treatment of psoriasis

The invention relates to medicine, particularly cardiology, and for the treatment of cardiovascular diseases, which shows the use of the drug ranolazine
Up!